In the ongoing battle against antibiotic resistance, a new study published in Engineering by Zhuoren Ling’s research team unveils a promising triple combination of antibiotics that significantly expands our arsenal against drug-resistant bacteria.
#ASCO24: A roundup of the latest data from Merus, MorphoSys and others
Read on for news about Immunocore, Arcus, CG Oncology, Genmab, Merck and GSK: Merus stock spikes on data in head and neck squamous cell carcinoma: